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Abstract
Background: Using risk stratification approaches to determine eligibility has the po-
tential to improve efficiency of screening.
Objectives: To compare the public acceptability and potential impact on uptake of 
using different approaches to determine eligibility for screening.
Design: An online population-based survey of 668 adults in the UK aged 45-79 in-
cluding a series of scenarios in the context of a potential kidney cancer screening 
programme in which eligibility was determined by age, sex, age and sex combined, 
a simple risk score (age, sex, body mass index, smoking status), a complex risk score 
additionally incorporating family history and lifestyle, or a genetic risk score.
Outcome measures: We used multi-level ordinal logistic regression to compare ac-
ceptability and potential uptake within individuals and multivariable ordinal logistic 
regression differences between individuals.
Results: Using sex, age and sex, or the simple risk score were less acceptable than 
age (P < .0001). All approaches were less acceptable to women than men. Over 70% 
were comfortable waiting until they were older if the complex risk score or genetics 
indicated a low risk. If told they were high risk, 85% would be more likely to take up 
screening. Being told they were low risk had no overall influence on uptake.
Conclusions: Varying the starting age of screening based on estimated risk from 
models incorporating phenotypic or genetic risk factors would be acceptable to most 
individuals and may increase uptake.
Patient or Public Contribution: Two members of the public contributed to the devel-
opment of the survey and have commented on this paper.
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1  | INTRODUC TION
Screening programmes seek to identify individuals with or at risk 
of developing disease to enable prevention or effective treatment. 
Most existing screening programmes are ‘one-size-fits-all’ with el-
igibility determined by age and/or sex and screening tests and in-
tervals standardized. However, within a population there is a wide 
range of risk of disease depending on individual factors, such as 
smoking status, body mass index (BMI), family history, lifestyle and 
genetics. There are, therefore, large differences in the absolute ben-
efits of screening and potential harms that an individual is likely to 
experience.
Targeted or stratified screening, in which the age of first invi-
tation, the choice of test and/or the screening interval are based 
on additional personal factors, has been proposed as a means 
of potentially improving efficiency.1-4 However, moving from a 
system in which population screening is based only on age and/
or sex, to one in which screening varies according to individu-
als’ risk of disease requires not only a valid and reliable means 
of estimating risk, but also consideration of many other aspects 
of implementation.4-6 In particular, any stratified screening pro-
gramme must be acceptable to the public and uptake high. This is 
reflected in the English National Screening Committee's updated 
criteria published in 2015, in which there is increasing focus on 
the acceptability of screening programmes as a whole (as op-
posed to only screening tests) to both participants and society.7 
Despite advances in the development of risk prediction models 
to estimate future risk, there remains little research on the views 
of the public towards introducing stratification into screening 
programmes.
Kidney cancer is the 9th most common cancer in men and the 
14th commonest cancer in women worldwide, and the incidence 
is increasing.8 The disease is largely curable if identified at an 
early stage. However, over half of all patients with kidney cancer 
are asymptomatic at the early stages and over a quarter have ev-
idence of metastases by the time of diagnosis when the five-year 
survival rate is only 12%.9 This has led to international interest 
among the scientific and lay community in developing a poten-
tial screening programme for this ‘silent’ cancer.10,11 As for other 
screening programmes, the cost-effectiveness of any programme 
would be highly dependent on prevalence of kidney cancer in those 
screened.12 Targeted screening of higher-risk individuals using es-
tablished risk factors is, therefore, like to be the most cost-effec-
tive strategy to maximize the benefits and reduce the harms of 
screening.13 The risk factors for kidney cancer overlap with those 
for many other cancers.14-17 Within the context of a potential new 
screening programme for kidney cancer, we therefore compared 
the public acceptability and potential impact on uptake of using 
different individual level characteristics, either alone or within risk 
prediction models, to determine eligibility for screening in order to 




An online population-based survey.
2.2 | Participants and recruitment
Participants were recruited through the Prolific platform (www.proli 
fic.ac). Individuals aged 45-79 years, with a Prolific approval rating 
(the proportion of prior studies completed by that participant that 
were judged by researchers as being of sufficient quality) over 95% 
were eligible to complete the survey. Inattentive participants were 
identified using a check question (‘It is important that you pay atten-
tion in this study. Please tick “strongly disagree”’) and excluded.18 We 
recruited a pragmatic sample of 1,021 adults. This analysis is based 
on data from 668 participants who correctly responded to the check 
question and resided in the UK.
2.3 | Survey
This study reports the results from the section of the survey that 
focused on attitudes towards different approaches to defining 
eligibility for screening. Questions in this section were developed 
with input from patient and public representatives and informed 
by questions from a previous study exploring attitudes towards 
cessation of low-value colorectal cancer screening that had been 
piloted using a think-aloud approach.19 As in that study, we pre-
sented participants with a series of hypothetical screening scenar-
ios. Before seeing the scenarios, participants were informed that a 
person's risk of developing kidney cancer depends on many factors 
and, specifically, that kidney cancer is more likely in older people, 
men, and people who smoke, are overweight or have a family his-
tory of kidney cancer. In each scenario that followed participants 
were then asked to imagine that they receive a letter inviting them 
to screening and justifying why they are being invited at that time. 
The first scenario used age alone to determine eligibility, with all 
individuals invited at age 60 because ‘kidney cancer does not usu-
ally occur in younger people’. The second used sex alone, with men 
being invited and women not because ‘men are 2-3 times more likely 
to develop kidney cancer than women’ and the third used both age 
and sex, with men being invited earlier than women. In the fourth 
scenario, eligibility was determined using a risk calculator incor-
porating age, sex, BMI and smoking status, with participants at 
higher risk invited at younger ages. No indication was given on 
the threshold used to determine eligibility for screening. The fifth 
scenario added family history and lifestyle to the risk calculator, 
and the final, sixth, scenario was based on genetic risk. After each 
scenario, acceptability was assessed by asking participants to rate 
how reasonable they thought it was to use the information in that 
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scenario to decide when individuals should be invited to screening 
and how comfortable they felt about that information being used. 
Responses were recorded on a 7-point Likert scale from 1 ‘Not at 
all reasonable/comfortable’ to 7 ‘Extremely reasonable/comfort-
able’. After each scenario, participants were also asked how com-
fortable they felt with not being offered screening or having to 
wait until they are older if they were low risk, again on a 7-point 
Likert scale. We also asked participants how acceptable it was to 
complete a questionnaire or provide a sample of blood or a cheek 
swab to enable estimation of their risk. Additionally, participants 
were asked how much being told they were at lower or higher risk 
would influence their decision to take up screening (on a 5-point 
Likert scale from 1 ‘Much less likely to attend’ to 5 ‘Much more 
likely to attend’).
The survey also included questions on key personal characteris-
tics: age, sex, ethnicity, BMI, education level, social class (classified 
as higher (ABC1) and lower (C2DE) based on the household's chief 
income earner's occupation category20,21), personal history of can-
cer and family history of kidney cancer.
Full details of all the scenarios and questions are in Appendix S1.
2.4 | Consent
Written online consent was obtained from each participant before 
they began the survey.
2.5 | Analysis
Data were weighted by age and sex within the UK so that the sam-
ple profile matched those of people aged 45-79 in the UK derived 
from the mid-year population in 2018 obtained from the Office of 
National Statistics.22 All results presented are from weighted data.
To enable us to compare the acceptability of the six different ap-
proaches to determining eligibility for screening, we generated a sin-
gle measure of acceptability on a scale from 1 to 7 by calculating the 
mean of how reasonable participants considered each approach and 
how comfortable participants were with that approach, with 1 indi-
cating ‘not at all acceptable’ and 7 indicating ‘extremely acceptable’. 
To compare the overall acceptability of the different approaches at 
a population level, we first summarized the distribution of accept-
ability scores for each of the six scenarios. This was performed 
separately for men and women as the questions relating to the sex 
and age and sex scenarios were different between the two sexes. 
To enable us to compare the relative acceptability of the different 
approaches at an individual level while accounting for the multiple 
responses from each participant, we then performed a two-level 
mixed-effects ordinal logistic regression with the single measure 
of acceptability treated as an ordinal variable and responses nested 
within participant, adjusted for age, social class and level of educa-
tion and stratified by sex. To further explore whether acceptability 
for each scenario was influenced by age, sex, social class or level of 
education, we additionally performed a series of multivariable or-
dinal logistic regression analyses with each approach separately as 
the dependent variable and age, sex, education level and social class 
as independent variables. We used the same approach to analyse 
how comfortable participants were with either not being screened 
or having to wait until they were older if they were low risk. In both 
cases, where data were missing for social class, participants with 
missing data were excluded from the regression models.
Responses from men and women were combined for analysis 
of the acceptability of data collection and the potential influence of 
being low or high risk on intention to take up screening. For both 
these outcomes, we summarized the data and then performed multi-
variable ordinal logistic regression with each outcome (acceptability 
and influence of being low or high risk on intention) as the depen-
dent variable to explore differences with age, sex, education level 
and social class.
We report all regression analysis results as odds ratios (ORs) with 
95% confidence intervals. All analyses were performed using Stata 
version 1423 with statistical significance set at P < .05.
3  | RESULTS
The characteristics of the 668 participants are shown in Table 1. 
Participants were distributed evenly by age group (237 (35.4%) aged 
45-54, 203 (30.4%) 55-64 and 228 (34.2%) 65 and over) and sex (343 
(51.3%) were female). Almost all (98%) described their ethnicity as 
white, most (75%) were in social classes ABC1 and 285 (42.7%) had 
university level education. There were < 5% missing data for social 
class (n = 32/668, 4.8%), body mass index (n = 29/668, 4.3%) and 
family history of kidney cancer (n = 14/668, 2.1%). All other ques-
tions in the survey were completed by all participants.
3.1 | Acceptability of using different approaches to 
determine eligibility for screening
Figure 1 shows the distribution of acceptability scores for men 
and women for different approaches to determine when individu-
als would become eligible for screening. Overall, 83% responded 
that it was acceptable (a score of ≥ 5 on the 7-point Likert scale) to 
use age, the more comprehensive risk score or a genetic risk score. 
This percentage was lower for a simple risk score (74.2%), for age 
and sex (65.0%) and lowest for sex alone (58.9%). This pattern was 
also seen at individual participant level in the multi-level ordinal re-
gression analyses, with sex, age and sex, and the simple risk score 
significantly (P < .0001) less acceptable than age, the complex risk 
score or genetic risk. Acceptability was the same for age, the com-
plex risk score and genetic risk for both male and female participants 
(Figure 2).
In multivariable analysis at population level (Table 2), using age, 
sex, age and sex, or the simple risk score were all more acceptable 
to men than women. Age, the more complex risk score and genetics 
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were also more acceptable to participants over 65 than to younger 
age groups. Sex, and age and sex were more acceptable to partic-
ipants with a university education than those with lower levels of 
education. No differences were seen with social class.
Similar patterns were seen when considering how comfortable 
participants would be either not being offered screening or having to 
wait until they are older if they were low risk (Figures 3 and 4). Both 
men and women were least comfortable with sex or age and sex 
alone being used to determine eligibility. In particular, only 36.9% 
of female participants were comfortable with not being offered 
screening at the same age as men. Men were more comfortable than 
women with the age one becomes eligible for screening being deter-
mined by sex (multivariable OR 2.05 (1.42-2.96), Table S1) but 32.2% 
of men were still not comfortable (a score of 3 or less). Over 70% of 
both men and women were comfortable (a score of 5 or more) with 
waiting until they were older if they were low risk based on the com-
plex risk score or genetics.
Participants over 65 were more comfortable than younger par-
ticipants waiting until they were older if they were low risk based on 
the simple risk score (age, sex, BMI and smoking), the more complex 
risk score and genetics. Those with a university education were also 
more comfortable with men being screened and women not than 
those with lower levels of education. No differences were seen with 
social class (Table S2).
3.2 | Acceptability of data collection to enable 
estimation of risk
40.3% (n = 269/668) and 46.9% (n = 313/668) responded that it was 
extremely acceptable to complete either a questionnaire or provide a 
sample of blood or cheek swab for genetic analysis, with 88% scoring 5 
or higher on the 7-point Likert scale and less than 6% scoring 3 or less 
(Figure S1). Participants aged over 65 years considered both methods 
of data collection more acceptable than those aged 45-54 years (mul-
tivariable OR 2.34 (95% CI 1.39-3.95) and 2.08 (1.20-3.62) for ques-
tionnaire and genetic samples, respectively). No differences were 
seen with sex, university education or social class (Table S2).
Participant characteristic
Unweighted n (%) or mean 
(± SD)
Weighted n (%) or 
mean (± SD)
Age
45-54 383 (57.3) 237 (35.4)
55-64 214 (32.0) 203 (30.4)
>65 71 (10.6) 228 (34.2)
Mean (± SD) 54.7 (± 7.0) 59 0.0 (± 8.4)
Sex (n, % female) 373 (55.8) 343 (51.3)
Social class
ABC1 500 (74.9) 501 (75.0)
C2DE 136 (20.4) 131 (19.6)
Missing 32 (4.8) 37 (5.5)
University level education 288 (43.1) 285 (42.7)
Ethnicity (n, % White) 653 (97.8) 657 (98.4)
Self-reported general health
Excellent, very good, good 524 (78.4) 534 (79.9)
Fair, poor 144 (21.6) 134 (20.1)
Smoking status
Non-smoker 340 (50.9) 318 (47.6)
Ex-smoker 236 (35.3) 257 (38.5)
Current smoker 92 (13.8) 93 (14.0)
BMI (kg/m2) (mean ± SD) 27.4 (± 5.8) 27.1 (± 5.3)
Missing 29 (4.3) 29 (4.3)
Previous diagnosis of cancer 34 (5.1) 44 (6.6)
Family history of kidney cancer
Yes 19 (2.8) 17 (2.6)
No 635 (95.1) 636 (95.2)
Missing 14 (2.1) 15 (2.2)
TA B L E  1   Characteristics of 
participants
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3.3 | Influence of being low or high risk on intention 
to take up screening
Almost half of participants responded that being told they are at low 
risk, based on a risk score incorporating either phenotypic and life-
style factors or genetic risk factors, would have no influence on their 
intention to take up screening (45.6% for a phenotypic and lifestyle 
risk score and 41.5% for a genetic risk score) (Figure 5A). The remain-
der were approximately evenly split between those who would be less 
likely to attend and those who would be more likely to attend, with the 
mean intention 3.12 (SD 1.05) and 3.28 (SD 1.08) on a scale from 1 to 5. 
When asked about the influence of being told they are at high risk, 85% 
of participants reported they would be more likely to attend with both 
types of risk score and only 2% less likely to attend (Figure 5B). No dif-
ferences were seen with age, sex, university education or social class.
F I G U R E  1   Acceptability of using either (A) Age, (B) Sex, (C) Age and sex, (D) Age, sex, BMI and smoking, (E) Age, sex, BMI, smoking, 
family history and lifestyle or (F) genetics to determine starting age of screening. Acceptability scores were measured on a Likert scale from 
1 indicating not at all acceptable to 7 indicating extremely acceptable. Dotted lines indicate the median response
F I G U R E  2   Odds (OR ± 95% confidence intervals) of considering using different approaches to determine the starting age of screening 
acceptable, adjusting for age, sex, level of education and social class and clustering of response by participant. The ORs represent the 
association between a 1-point increase in acceptability (measured on a Likert scale from 1 indicating not at all acceptable to 7 indicating 
extremely acceptable) and the approach to determining eligibility. * P < .0001 compared with using age
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4  | DISCUSSION
Identifying strategies that are acceptable to the public has been 
recognized as one of the challenges to implementation of risk-
stratified screening.2-5 In the context of a potential new screen-
ing programme for kidney cancer, we have shown that using risk 
models based on genetic risk factors or age, sex, BMI, smoking, 
family history and lifestyle to determine eligibility for screen-
ing is as acceptable as using age alone for both men and women. 
Furthermore, over 70% of participants were comfortable with 
waiting until they were older if they were low risk. In contrast, 
using sex or a combination of age and sex, in which only men (who 
F I G U R E  3   Comfort with waiting until older if low risk based on (A) Sex, (B) Age and sex, (C) Age, sex, BMI and smoking, (D) Age, sex, BMI, 
smoking, family history and lifestyle or (E) genetics to determine starting age of screening. Comfort scores were measured on a Likert scale 
from 1 indicating not at all comfortable to 7 indicating extremely comfortable. Dotted lines indicate the median response
F I G U R E  4   Odds (OR ± 95% confidence intervals) of being comfortable with waiting until older if low risk based on different 
characteristics, adjusting for age, sex, level of education and social class and clustering of response by participant. The ORs represent 
the association between a 1-point increase in comfort (measured on a Likert scale from 1 indicating not at all comfortable to 7 indicating 
extremely comfortable) and the approach to determining risk. * P < .05 compared with using age, sex, BMI, smoking, family history and 
lifestyle
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are at higher risk of kidney cancer) are invited or men are invited 
at a younger age than women, was less acceptable than age alone, 
with up to half of women and a third of men not comfortable with 
using sex, and both approaches less acceptable to women than 
men.
4.1 | Comparison with existing literature
To our knowledge, this is the first study to report the public ac-
ceptability of using different individual level characteristics either 
alone or within risk prediction models to determine initial eligibil-
ity for screening. A survey of veterans in the US explored attitudes 
towards using age or a risk score to decide when to stop colorectal 
cancer screening.19 They found that participants were divided over 
the use of both age or a risk score, with 22% and 24.3% respectively 
responding that using age or a risk score was not at all reasonable 
and 16.3% and 11.3% responding that each was extremely reason-
able. Age was considered more reasonable overall than using a risk 
score in that study, although that may reflect a preference for status 
quo that has been reported in previous studies.24
Other studies have focused on attitudes towards changes in 
the frequency of screening. In general, these have found that mem-
bers of the public are positive towards being offered more screen-
ing but are concerned about the possibility of less screening.24-27 
Although a significant proportion of participants in this study were 
uncomfortable about only men having screening and a significant 
proportion of women uncomfortable about having to wait until they 
were older than men for screening, most (>70%) were comfortable 
waiting until they were older to start screening if they were low risk 
when that risk was based on a risk score or genetic risk. It is pos-
sible that delaying the start of screening based on risk scores may 
be more acceptable than extending the interval between screening 
episodes.
The high levels of acceptability for either completing a question-
naire or providing a cheek swab or blood sample for genetic testing 
mirror the general support for cancer risk assessment seen in other 
screening contexts. In surveys of the general public, for example, 
85% of women report that they would be likely to take up genetic 
testing for ovarian cancer risk,28 94% of women would take up risk 
assessment for breast cancer29 and 94% of respondents were inter-
ested in knowing their risk of breast or prostate cancer.30 The greater 
acceptability among older participants seen in this study may reflect 
a more general greater familiarity and comfort with blood testing.
The finding that being told that they are low risk is unlikely to 
have a significant effect on subsequent uptake, while being told high 
risk might increase uptake, is also consistent with the findings from 
a UK-based study in which women were given their risk of breast 
cancer in the context of breast cancer screening: re-attendance was 
significantly higher for women told they were at high risk than usual 
re-attendance rates but was not significantly lower for those told 
they were at low risk.31 This may reflect an overall enthusiasm for 
screening32 or just being invited may be sufficient for some indi-
viduals to consider they should take up screening, with information 
about their risk not being a factor in that decision. How much these 
changes in intention observed in this study might influence uptake 
is also not known. These findings, together with the wider body of 
literature concerning the impact of provision of personalized risk in-
formation,33-35 however, suggest that informing individuals of their 
risk is unlikely to substantially reduce overall screening uptake and 
may increase uptake.
4.2 | Strengths and limitations
A key strength of this study is that the survey was informed by ques-
tions developed in a previous study19 using a think-aloud approach 
and informed by input from patient and public representatives to 
F I G U R E  5   Influence of being (A) low risk and (B) high risk on likelihood of attending screening for both a phenotypic and lifestyle risk 
score and a genetic risk score
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maximize readability for participants. While we provided estimates 
of the relative risks of many of the risk factors included in the dif-
ferent scenarios, we did not, however, provide detailed quantitative 
estimates of the risks and benefits of screening in each scenario, ac-
curacy of the risk models, or the population-level impacts of invit-
ing groups of individuals at different times. It is possible that the 
participants’ views may have been different had we presented this 
additional information. The wording also varied slightly between 
the individual scenarios. Specifically, in the age-based scenario par-
ticipants were informed that ‘kidney cancer does not usually occur in 
younger people’ while in the scenarios including sex the participants 
were informed that ‘kidney cancer is 2-3 times more common in men 
than women’. Additionally, in all the risk model–based scenarios no 
indication was given of the thresholds that might be used to cat-
egorize individuals as at higher or lower risk but participants were 
explicitly informed that the risk calculator is not 100% reliable. The 
more certain framing used in the age-based scenario could explain 
in part the high levels of acceptability for using age alone to identify 
individuals for screening. The order of the questions may also have 
impacted on the results as the scenarios were not randomized and so 
information presented in earlier scenarios may have influenced how 
participants responded to later scenarios. Such context effects are 
thought to occur through a number of distinct cognitive processes, 
including priming effects, in which the beliefs around an earlier 
question trigger a similar response to later questions, and anchor-
ing, in which information presented earlier influences comparative 
judgements about later questions.36 It is difficult to predict these 
effects37 and, in turn, how they may have impacted on our findings. 
Experimental studies suggest, however, that while question order 
effects may affect responses to individual items, they do not affect 
the relationships between responses or correlations with participant 
characteristics.37
Asking these questions in the context of a hypothetical new 
screening programme could also be considered a strength as it re-
duced the likelihood of our findings being biased by a preference 
for status quo screening. However, it is possible that the partic-
ipants’ views may have been different if we had used scenarios 
within the context of screening programmes for other conditions 
such as colorectal, breast or prostate cancer. Although the risk 
factors included in this study are the same as the risk factors 
for other cancers15-17 and the strategies similar to those being 
considered for these existing screening programmes,2,38,39 our 
findings may not therefore be generalizable across all screening 
programmes.
Another strength is the large sample size that allowed us to ex-
plore differences in acceptability at both the population and indi-
vidual level. However, to achieve this we used an online recruitment 
platform which potentially limits generalizability. In particular, mem-
bers of the platform (Prolific) are experienced at completing online 
studies and their views may not be representative of the general 
population,40 particularly those with lower literacy levels and those 
without internet access. The demographics of members are also 
different from the general UK population. The main differences in 
our cohort compared with UK census data from 2011 were in social 
class and ethnicity: 74.9% of our participants reported being in the 
upper half of the social classes (ABC1), compared with 53.0% of the 
UK population41; and 97.8% reported being of white ethnicity, com-
pared with 86% in the UK.42 The proportion with university educa-
tion, number of current smokers and mean BMI were all similar to 
the UK population.43-45 To enable our population to reflect the age 
and sex distribution across the UK, we weighted the analysis by age 
and sex. While this application of weights makes the findings more 
generalizable to the UK population, it does not however, eliminate 
the risk of bias as the approach is equivalent to replacing members of 
under-represented subgroups with replicates of participating mem-
bers of the same subgroup. This approach also does not account for 
differences in social class or ethnicity, or for potential differences 
in attitudes between those registered with the online recruitment 
platform and the wider population.
5  | CONCLUSION
This study suggests that changing the starting age of screening 
based on estimated risk from risk models incorporating either phe-
notypic or genetic risk factors would be acceptable to the majority 
of individuals and may lead to increased uptake. Further work is now 
needed to explore the wider social and ethical implications of risk 
stratified screening for society as a whole.
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